Alkermes says API demand is safe; Oxygen taps PPD for Phase IIb;

> Alkermes ($ALKS) says the CMO demand for highly potent APIs can withstand Big Pharma in-sourcing. Article

> CROs need to diversify to survive, according to Catalyst Corporate Finance, as the market favors operations that can fill as many R&D roles as possible. Story

> Outsourcing-Pharma held a reader poll to determine just what "CRO" stands for in the minds of industry players. More

> Oxygen Biotherapeutics ($OXBT) has tapped PPD to conduct a Phase IIb clinical trial for Oxycyte, a brain injury treatment. News

> Icon ($ICLR) has reached out to Wingspan Technology for its cloud-based clinical trial system. Item

> CRO Onyx Scientific has named Dan Brisard its business development director. Release

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

WCG is continuing its buyout run after acquiring clinical trial solutions firm Trifecta Clinical.

London-based uMed has raised nearly $4.8 million from U.K. and U.S. VCs to help healthcare providers participate in more clinical studies.

Amgen has teamed up with cloud-based trial solutions firm Reify Health to help boost patients into its drug studies.